📰 New real-world data from the Adelphi Real World Haemophilia Disease Specific Programme underline persistent unmet needs in haemophilia and the continued challenge of aligning treatment outcomes with patient priorities 🔗 @haemophilia_jnl onlinelibrary.wiley.com/doi/10.1111/...
Introduction
Prophylactic factor replacement and non-factor therapy has improved bleed prevention and clinical outcomes for people with haemophilia (PwH). The remaining burdens faced by PwH in real-.....
